MapLight Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	46.73	38.25	79.77	27.67
Short-Term Investments	258.37	70.54	-	-
Cash & Short-Term Investments	305.1	108.8	79.77	27.67
Cash Growth	180.44%	36.39%	188.34%	-
Prepaid Expenses	19.57	5.81	3.84	4.37
Total Current Assets	324.67	114.6	83.6	32.03
Property, Plant & Equipment	6.58	7.56	6.59	7.12
Long-Term Investments	147.99	11.38	0.99	-
Long-Term Deferred Charges	-	3	-	-
Other Long-Term Assets	0.27	0.37	0.23	0.23
Total Assets	479.51	136.92	91.41	39.39
Accounts Payable	3.29	1.91	3.25	3.6
Accrued Expenses	12.05	9.99	6.76	2.79
Current Portion of Leases	0.89	0.78	0.5	0.35
Current Unearned Revenue	-	3.24	4.2	5.86
Total Current Liabilities	16.23	15.92	14.7	12.6
Long-Term Leases	4.91	5.8	5.43	5.92
Total Liabilities	21.14	21.72	20.13	18.52
Common Stock	0.01	-	-	-
Additional Paid-In Capital	819.12	5.58	4.2	3.12
Retained Earnings	-360.52	-199.37	-121.79	-66.08
Comprehensive Income & Other	-0.23	0.16	-	-
Total Common Equity	458.37	-193.63	-117.59	-62.96
Shareholders' Equity	458.37	115.2	71.28	20.87
Total Liabilities & Equity	479.51	136.92	91.41	39.39
Total Debt	5.8	6.58	5.92	6.27
Net Cash (Debt)	299.3	102.22	73.85	21.39
Net Cash Growth	192.81%	38.42%	245.17%	-
Net Cash Per Share	34.48	138.85	111.94	38.41
Filing Date Shares Outstanding	44.02	0.76	0.67	0.56
Total Common Shares Outstanding	44.02	0.76	0.67	0.56
Working Capital	308.44	98.68	68.91	19.44
Book Value Per Share	10.41	-254.32	-176.19	-113.03
Tangible Book Value	458.37	-193.63	-117.59	-62.96
Tangible Book Value Per Share	10.41	-254.32	-176.19	-113.03
Machinery	3.69	3.25	2.77	2.22
Leasehold Improvements	-	-	0.01	-

Source: S&P Capital IQ. Standard template. Financial Sources.